Brief: Bellicum Pharmaceuticals Reports Q2 2019 Results
05/08/2019 23:19
Aug 5 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS REPORTS SECOND QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES OPERATIONAL UPDATE
* QTRLY LOSS PER SHARE $0.58
Source text for Eikon: ID:nGNX4G5GKf
Further company coverage: BLCM.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview